Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Researchers suggest results could reignite interest in DLK inhibition as a treatment strategy for neurodegenerative diseases.

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Sponsored content brought to you by NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.

Study in older adults found that individuals who received the shingles vaccine were 20% less likely to develop dementia than those who were unvaccinated.

AIR-001 is designed to restore functional alpha-1 antitrypsin (M-AAT) protein production by precisely repairing the SERPINA1 mutation (PiZ) to address the underlying cause of both lung and liver ...

Breast, pancreatic, and prostate cancers have a disproportionately higher rate of aggressive tumor grade in the target population.

IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...

In episode one of this podcast, you’ll hear a group of experts discussing base editing and how the technology is helping ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...